Pharmacokinetics of multiple oral doses of acetaminophen in equine neonates

Abstract

Abstract OBJECTIVE To determine the pharmacokinetics and clinical safety of acetaminophen after oral administration of 40 mg/kg q 12 hours or 60 mg/kg q 24 hours for 14 days. ANIMALS 12 healthy light-breed neonatal foals. PROCEDURES 6 foals received acetaminophen at 40 mg/kg q 12 hours and 6 foals received 60 mg/kg q 24 hours for 14 days. The study dates were January 31 to April 15, 2023. Physical examinations were performed daily. Plasma disposition of acetaminophen was determined after the first, mid-point drug administration. Hematology and biochemistry analysis was performed before the study, day 7, and the last day of drug administration. Plasma acetaminophen concentrations were determined by high-performance liquid chromatography. Plasma pharmacokinetic parameters were estimated using noncompartmental analysis. RESULTS No statistically significant changes occurred on hematology or biochemistry profiles. Elevations in γ-glutamyl transferase (GGT) and sorbitol dehydrogenase (SDH) were noted in 4 foals at various time points. The maximum plasma concentration (Cmax) occurred within 2 hours for both doses. The 60 mg/kg dose resulted in a larger median Cmax (range) at 28 μg/mL (22–32) than the 40 mg/kg dose at 23 μg/mL (19–27). The median area under the concentration-vs-time curve from 0 to 8 hours (AUC0–8 hour [range]) was 100 h•µg/mL (82–100) at 40 mg/kg and 128 h•µg/mL (120–168) for 60 mg/kg. Trough concentrations decreased over time for both regimens. CLINICAL RELEVANCE Foals tolerate oral acetaminophen at 40 mg/kg q 12 hours or 60 mg/kg q 24 hours. Further analgesic and antipyretic studies will help to delineate optimal dosage regimens of acetaminophen to treat foals.